Caitong International Asset Management Co., LTD Atai Life Sciences N.V. Call Options Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$6.96 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.73 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$2.05 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.98 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $347M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...